Up 15% in 13 days, is it too late to buy South32 shares?

South32 shares have risen 1%-plus per day for the past 13 trading days. Have investors missed the boat?

| More on:
a man in a hard hat and high visibility vest smiles as he stands in the foreground of heavy mining equipment on a mine site.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

South32 Ltd (ASX: S32) shares are trading at $3.33 on Friday, up 0.3% for the day so far.

This diversified ASX 200 mining share has been on a bit of a tear of late.

South32 shares have risen 15.22% over the past 13 trading days.

As the chart below shows, South32 shares closed at $2.89 apiece on 26 March.

That wasn't far off the stock's 52-week low of $2.75, which it reached on 21 February.

Had you put $10,000 into South32 shares 13 days ago, they'd be worth $11,522.40 now.

So, many of us missed a nice little buy-the-dip opportunity there.

But not to worry.

One top broker reckons it's not too late to buy South32 shares.

Here's why.

Should you buy South32 shares?

Top broker Goldman Sachs has a buy rating on South32 shares with a 12-month price target of $3.80.

That implies a potential 14% upside for investors who buy the ASX mining stock today.

In a new note last week, Goldman said South32 shares have a net asset value (NAV) of $3.80. The NAV measures the value of a company's assets less its liabilities, divided by the number of shares outstanding.

Goldman said that South32 and Rio Tinto Ltd (ASX: RIO) look undervalued on a price-per-NAV basis compared to the two biggest mining shares, BHP Group Ltd (ASX: BHP) and Fortescue Ltd (ASX: FMG).

The broker noted that South32 has reported reduced Australian manganese production and sales in CY24 against increased low-grade 37% manganese pricing.

This may go some way to explaining why the broker has reduced its earnings per share (EPS) estimate for FY24 from 13 cents per share to 10 cents per share.

But don't worry about that, because the future looks bright.

Goldman is estimating a three-fold increase in EPS the very next year.

For FY25, Goldman expects EPS of 31 cents per share, rising to 36 cents per share in FY26.

Why does Goldman Sachs say buy?

In addition to viewing the South32 share price as undervalued, Goldman is also bullish on copper, aluminium and metallurgical coal and South32 mines all three of them.

Goldman explains:

Buy rated on: (1) Improving FCF in 2H FY24: GS are bullish copper, aluminium, and met coal (~65% of S32 NTM EBITDA) in CY24E. (2) Attractive valuation trading at ~0.8xNAV on our estimates plus potential +A20cps upside based on recently announced sale of the Illawarra metallurgical coal operation to Golden Energy and Resources (GEAR) and M Resources for a total consideration of up to US$1.65bn (~A52cps), assuming the transaction completes as planned in 1H FY25; …

Looking ahead, Goldman expects South32 to report a fall in net debt to approximately US$500 million by the end of June.

That's well below South32's net debt target of US$1 billion to US$1.5 billion through the cycle.

As a result, the broker reckons South32 may announce the resumption of its on-market share buyback at about US$250 million per annum when the miner releases its FY24 results.

The broker also expects an improving dividend yield from 2% in FY24 to 6% in FY25, assuming South32 pays its minimum dividend payout ratio of 40% of earnings.

Goldman also predicts upside potential from various base metal growth projects.

The broker said:

… there are numerous growth projects/options that should provide long dated base metals growth; Sierra Gorda brownfields (4th milling line & oxide projects), battery grade manganese sulphate from the Clarke deposit at Hermosa + the Peake copper prospect, and copper/gold/cobalt from the Ambler Metals JV in Alaska.

Motley Fool contributor Bronwyn Allen has positions in BHP Group and South32. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended Goldman Sachs Group. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Broker Notes

A man clenches his fists in excitement as gold coins fall from the sky.
Broker Notes

These ASX 300 shares could rise 35% to 65%

Analysts are tipping these shares to rise strongly from current levels. How high could they go?

Read more »

a man in a high visibility vest and hard hat holds a thumbs up at a mine site with heavy equipment in the background.
Broker Notes

What are brokers saying about BHP shares following the miner's quarterly results?

Analysts have crunched the numbers.

Read more »

A businessman looking at his digital tablet or strategy planning in hotel conference lobby. He is happy at achieving financial goals.
Broker Notes

Brokers name 3 ASX shares to buy now

Here's why brokers are feeling bullish about these three shares this week.

Read more »

Man on a laptop thinking.
Broker Notes

Why did Goldman Sachs just downgrade Wesfarmers shares?

The ASX 200 conglomerate has had a ripper run of share price growth. So why is Goldman Sachs downgrading it?

Read more »

A man holds his head in his hands, despairing at the bad result he's reading on his computer.
Broker Notes

Why these 4 ASX 200 shares just got downgraded by top brokers

Leading brokers have downgraded their outlooks for these ASX 200 shares. But why?

Read more »

Investor sitting in front of multiple screens watching share prices
Broker Notes

Top brokers name 3 ASX shares to buy today

Here's what brokers are recommending as buys this week.

Read more »

A young man wearing a black and white striped t-shirt looks surprised.
Broker Notes

Why this beaten-down ASX 200 stock can jump 24%

Goldman Sachs thinks this sold off stock could generate big returns for investors.

Read more »

Man with a sleep apnoea mask on whilst sleeping.
Broker Notes

ResMed shares higher as company 'turns the GLP threat into an opportunity': Fundie

ResMed is having a great run in 2024 with the share price up 29% already.

Read more »